These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24659124)
1. Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants. Azizi G; Haidari MR; Khorramizadeh M; Naddafi F; Sadria R; Javanbakht MH; Sedaghat R; Tofighi Zavareh F; Mirshafiey A Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):198-206. PubMed ID: 24659124 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of dasatinib in mouse model of multiple sclerosis. Azizi G; Goudarzvand M; Afraei S; Sedaghat R; Mirshafiey A Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):287-94. PubMed ID: 25975582 [TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate: an innovation in treatment of autoimmune diseases. Azizi G; Mirshafiey A Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):259-67. PubMed ID: 23947692 [TBL] [Abstract][Full Text] [Related]
4. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. Aminian A; Noorbakhsh F; Ghazi-Khansari M; Kafami L; Javadi S; Hassanzadeh G; Rahimian R; Dehpour AR; Mehr SE Neuroscience; 2013 Sep; 248():299-306. PubMed ID: 23774631 [TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis. Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523 [TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models. Gobin B; Moriceau G; Ory B; Charrier C; Brion R; Blanchard F; Redini F; Heymann D PLoS One; 2014; 9(3):e90795. PubMed ID: 24599309 [TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
10. In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice. Kandagaddala LD; Kang MJ; Haque MM; Im HY; Seo JE; Chung BC; Jung BH; Patterson TA; Kwon OS J Neurol Sci; 2012 Jul; 318(1-2):36-44. PubMed ID: 22554692 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971 [TBL] [Abstract][Full Text] [Related]
12. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis. Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992 [TBL] [Abstract][Full Text] [Related]
13. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells. Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic approach by Aloe vera in experimental model of multiple sclerosis. Mirshafiey A; Aghily B; Namaki S; Razavi A; Ghazavi A; Ekhtiari P; Mosayebi G Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):410-5. PubMed ID: 20233107 [TBL] [Abstract][Full Text] [Related]
15. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666 [TBL] [Abstract][Full Text] [Related]
16. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803 [TBL] [Abstract][Full Text] [Related]
18. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H; Zhang H; Liu F; Qi Y; Jiang H Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Kassis I; Petrou P; Halimi M; Karussis D Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102 [TBL] [Abstract][Full Text] [Related]
20. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis. Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]